NanoBio Awarded U.S. Patent for RSV Vaccine

NanoBio Corporation today announced the issuance of U.S. Patent No. 9,492,525 Human Respiratory Syncytial Virus (RSV) Vaccine. The patent broadly covers the composition of NanoBio’s intramuscular and intranasal RSV vaccine candidates, which combine the company’s innovative nanoemulsion (NE) adjuvant with strain L19 of RSV.  RSV is a highly contagious viral disease and is one of the … Continued

Blue Medora Expands Leadership Team

Blue Medora, a leading innovator in IT operational analytics (ITOA) for enterprise cloud, database and infrastructure management, today announced the appointment of three global vice presidents and an EMEA sales director to support its rapid worldwide growth. Link to news release